HLS vs VIT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

54MEDIUM

VIT

VITURA FPO [VIT]

49LOW

Score Breakdown

HLS VIT
Technical
68
53
Catalyst
87
51
Sentiment
50
50
Fundamental
90
76
Momentum
34
28
Risk Gate
32
45

Key Metrics

HLS Metric VIT
$275.9MMarket Cap$18.6M
4.3MAvg Volume (20d)682K
+10.1%Short InterestN/A
$1.07052-Week High$0.075
$0.30052-Week Low$0.021
+3.2%Daily Change+3.6%
$0.392Reference Price$0.029
-69.3%ROE+1.2%
-12.3%Profit Margin+0.6%

Active Signals

HLS Signals

MACD momentum is picking up steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading above both moving averages — the trend is your friend here
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.2x)
EPS estimates revised upward (+10pts)
Near 52-week low (10% of range)

VIT Signals

MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.1x)
Moderate revenue growth (+8%)
Near 52-week low (13% of range)
Micro-cap ($5-20M) - high risk

Ask Scout AI to compare HLS and VIT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HMD vs IBX →HMD vs IMU →HMD vs PKY →HMD vs PYC →HMD vs RCE →
HLS Full Analysis → VIT Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).